Table 2. AUC Values Determined on Training and Test Sets of Best Performing Ensembles Selected To Maximize AUCa.
androgen receptor |
CDK2 |
PPAR-δ |
|||||||
---|---|---|---|---|---|---|---|---|---|
method | size | training | test | size | training | test | size | training | test |
exhaustive | 6 | 0.894 ± 0.05 | 0.850 ± 0.04 | 4 | 0.934 ± 0.014 | 0.919 ± 0.019 | 6 | 0.950 ± 0.020 | 0.923 ± 0.023 |
slow heuristic | 5 | 0.893 ± 0.04 | 0.850 ± 0.04 | 4 | 0.934 ± 0.014 | 0.919 ± 0.019 | 6 | 0.950 ± 0.020 | 0.923 ± 0.02 |
fast heuristic | 3 | 0.890 ± 0.03 | 0.850 ± 0.04 | 4 | 0.934 ± 0.014 | 0.919 ± 0.019 | 8 | 0.942 ± 0.022 | 0.928 ± 0.03 |
The column labeled “size” gives the number of target conformations in the optimally performing ensemble identified by each method; 95% confidence intervals are given. Androgen receptor ensembles were constructed from 10 MD conformations identified using pocket volume clustering and a crystal structure. CDK2 ensembles were constructed from five MD conformations identified using RMSD-based pocket clustering and a crystal structure. PPAR-δ ensembles were constructed from 12 crystal structures.